Cargando…
Inhibition of p53 prevents diabetic cardiomyopathy by preventing early-stage apoptosis and cell senescence, reduced glycolysis, and impaired angiogenesis
Elevated tumor suppressor p53 expression has been associated with heart diseases, including the diabetic heart. However, its precise role in the pathogenesis of diabetic cardiomyopathy (DCM) remains unclear. We hypothesized that the development of DCM is attributed to up-regulated p53-mediated both...
Autores principales: | Gu, Junlian, Wang, Shudong, Guo, Hua, Tan, Yi, Liang, Yaqin, Feng, Anyun, Liu, Qiuju, Damodaran, Chendil, Zhang, Zhiguo, Keller, Bradley B., Zhang, Chi, Cai, Lu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833384/ https://www.ncbi.nlm.nih.gov/pubmed/29362483 http://dx.doi.org/10.1038/s41419-017-0093-5 |
Ejemplares similares
-
Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
por: Gu, Junlian, et al.
Publicado: (2017) -
p53 action in apoptosis and senescence
por: Lowe, SW, et al.
Publicado: (2000) -
Inhibition of autophagy prevents cadmium-induced prostate carcinogenesis
por: Pal, Deeksha, et al.
Publicado: (2017) -
Cardioprotective effects of fibroblast growth factor 21 against doxorubicin-induced toxicity via the SIRT1/LKB1/AMPK pathway
por: Wang, Shudong, et al.
Publicado: (2017) -
Diabetic Cardiomyopathy and Its Prevention by Nrf2: Current Status
por: Chen, Jing, et al.
Publicado: (2014)